Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:27 PM
Ignite Modification Date:
2025-12-24 @ 1:27 PM
NCT ID:
NCT02533895
Eligibility Criteria:
Inclusion Criteria:
Inclusion criteria for the safety and feasibility testing of AV0113
* Male and female patients with a malignant neoplasia shall be eligible for this protocol provided they have no more "conventional" treatment options and have measurable disease. There is no age limit for participation in this study provided that the tumour is typical for the group of refractory solid neoplasias of childhood.
* Patients must not be HIV-positive.
* Patients must have primary tumour tissue or cells available at sufficient number to allow treatment according to the protocol.
* Patients or legal guardians must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects. Patients or their guardians will be given a copy of the consent form.
Inclusion criteria for patients included in the long-term follow up and comparison with historic controls
* Patients suffering from bone or soft tissue sarcoma that received treatment with AV0113 or are documented in the database of the Medical University Vienna's Department of Orthopaedics.
* At least one disease recurrence after first CR or worse disease condition (e.g.: never reached CR).
* Diagnosis between 1992-2003 and/or "inclusion time point" during the years 2000-2004.
* Availability of date of death or of confirmation that patient is still alive (for the currentness of confirmation that patients are still alive only the time span from 1 April 2014 to 1 April 2015 is accepted).
* Patients not older than 27 years at their ITP.
Exclusion Criteria:
Exclusion criteria for the safety and feasibility testing of AV0113
* Any of the inclusion criteria not met.
* Any condition which, in the investigator's opinion, may pose a risk to the patient or will interfere with the study objectives.
Exclusion criteria for patients included in the long-term follow up and comparison with historic controls
* Date of "inclusion time point" and death or confirmation that patient is still alive at time of evaluation not available.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02533895
Study Brief:
Protocol Section:
NCT02533895